Tipsheet
What matters at India’s listed companies
Pesticides · Small cap

Excel Industries pulls its margin guidance after reporting just 10.1% EBITDA.

The company withdrew its 13-15% EBITDA target for the ongoing business, citing El Niño and geopolitical risks. A key contract has not moved beyond validation batches.

2 earlier stories on Excel Industries Ltd.
Mkt cap₹1,140 cr
P/E15.06×
ROE5.37%
Debt / eq.0.00
Div yld1.51%
10.1% FY26 EBITDA margin, short of the withdrawn 13-15% target.

What's new

  • Management withdrew its prior EBITDA margin guidance of 13-15% for the ongoing business.
  • The company said a key contract manufacturing agreement has only reached validation batches, not commercial supply.
  • The capex plan of Rs 200-300 crore remains on track, with a dedicated line expected by July 2026.

Why this matters

Withdrawing guidance is a red flag for any company, but especially for a micro-cap with thin margins. The regression on the contract manufacturing deal suggests earlier claims were premature, tightening the execution timeline for both revenue and margin recovery.

What we're watching

  • Progress on the contract manufacturing agreement beyond validation batches.
  • Commissioning of the dedicated production line by July 2026.
  • Impact of monsoon risks and geopolitical disruptions on raw material costs.

The full read

Excel Industries reported a FY26 EBITDA margin of 10.1%, then withdrew its guidance of 13-15% for the ongoing business, blaming El Niño and geopolitical risks. That is a significant gap to explain. The news gets worse: a key multinational contract manufacturing deal, previously described as commercially active, is still stuck in validation batches. For a micro-cap, these are material setbacks to the near-term story. The Rs 200-300 crore capex plan and a new production line due by July 2026 remain on track, but they now sit against a backdrop of missed targets and scaled-back commitments. The withdrawal changes the earnings conversation.

Questions answered

Why did Excel Industries withdraw its EBITDA margin guidance?
Management pulled the 13-15% target for the ongoing business after reporting a FY26 margin of only 10.1%. They cited El Niño monsoon risks and geopolitical disruptions to raw materials as the reasons for the uncertainty.
What is the status of the major contract manufacturing agreement?
The company clarified that the deal has only progressed to dispatched validation batches. This is a step back from earlier statements that commercial supplies had commenced.
Is the Rs 200-300 crore capex plan still on schedule?
Management maintained a cautiously optimistic outlook on the capex. It includes a dedicated production line they are targeting to commission by July 2026.
How does the FY26 margin compare to the old guidance?
The reported FY26 EBITDA margin was 10.1%, which was well below the previously stated structural target range of 13-15% that the company has now withdrawn.
Mentioned: Excel Industries · 13-15% EBITDA guidance · Rs 200-300 crore capex
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Excel Industries Ltd.

Chemicals
₹1,255 cr
P/E 16.57×

Latest quarter · Mar 2026

Sales₹281 cr
Net profit₹12 cr
Op. margin+7.8%
EPS₹9.77

Strength & growth

Debt / equity0.00×
Current ratio3.19×
Sales CAGR+9.1%
EPS CAGR+11.0%
  1. 25 May 2026 · 5:12 PM IST Excel Industries pulls its margin guidance after reporting just 10.1% EBITDA.
  2. 45d ago Excel Industries reports a 12% profit decline for FY26
  3. 45d ago Excel Industries reports revenue growth as margins slip